<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File Number 0-16964
NOTIFICATION OF LATE FILING
(Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form
N-SAR For Period Ended: February 28, 1999 [ ] Transition Report on Form 10-K [ ]
Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition
Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition
Period Ended:
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
Part I. Registrant Information
Full Name of Registrant: Cancer Treatment Holdings, Inc.
Former Name if Applicable: N/A
c/o Carol O'Donnell, Esq., 540 Joan Drive, Fairfield, CT 06430-2207
Address of principal executive office (Street and Number),
City, State and Zip Code
Part II. Rule 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
(Check box if appropriate.)
: (a) The reasons described in reasonable detail in Part III
: of this form could not be eliminated without unreasonable
: effort or expense;
:
[X] : (b) The subject annual report, semi-annual report, transition
: report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
: thereof will be filed on or before the 15th calendar day
: following the prescribed due date; or the subject quarterly
: report or transition report on Form 10-Q, or portion thereof
: will be filed on or before the fifth calendar day following
: the prescribed due date;
and
: (c) The accountant's statement or other exhibit required by
: Rule 12b-25(c) has been attached if applicable.
Part III. Narrative
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q, N- SAR or the transition report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)
Page 1 of 3 Pages
<PAGE>
An extension of time in filing Form 10-QSB is required. The registrant
was only able to obtain confirmation of certain asset valuations after the close
of business today. The registrant expects its Form 10-QSB to be filed
immediately after acceptance of this filing.
Part IV. Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
Carol O'Donnell (203) 254-7765
--------------- --------------
Name Area Code and Telephone Number
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Explanation to Part IV, Item (3): The registrant sold substantially all
of its assets (comprised of operating subsidiaries) and liabilities as of May
31, 1998 and November 20, 1998.
Cancer Treatment Holdings, Inc.
-------------------------------
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: April 14, 1999 By: /s/ Carol O'Donnell
-------------- --------------------
Carol O'Donnell
Secretary
Instruction. The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
-2-
